Mark Luttmann Email & Phone Number

Program Manager for COPD360Net, the Foundation’s initiative to facilitate, review, and expedite clinical trials for new therapies and digital health tools. Support for COPD360Net projects and activities including emergent clinical study endeavors. Management of application process and communications involving COPD360Net’s accredited centers and.

King Of Prussia, Pennsylvania, United States

• Strategy and operations support for international innovative R&D teams that focused on internal target incubation, lead optimization, external academic partnerships, global health and diseases of the developing world.
• Implementation of R&D Strategy and Operations Initiatives - Managed R&D procurement activities, financial coding, and business intelligence reporting (ERP, Hyperion). - Development and production of materials for R&D.
• Administered GSK Discovery Fast Track Challenge 2013-2018; processed over 1300 applications from academic institutions across North America, Europe and Australia; 35 winners selected to collaborate with GSK.
• Respiratory Pipeline Asset support; pre-clinical pharmacology contact for COPD & asthma assets; verification of content for regulatory documents
• WADA Anti-Doping Coordinator; implementation and management of GSK’s cooperation initiative with the World Anti-Doping Agency (WADA). Established R&D WADA Cooperation webpage and internal risk assessment including.
• Communications Development and Execution - Designed and managed R&D website communities (SharePoint) in-line with GSK Brand standards; worked with GSK R&D Communications team members to refresh the primary internal web.

King Of Prussia, PA

• Scientist in laboratory conducting in vitro investigation of functional mechanisms of airway and vascular smooth muscle contraction with a focus on lead optimization and target validation activities.
• Broad scientific expertise and understanding of pharmacological and physiological principles and methods in relation to human airway diseases such as COPD and asthma.
• Human biological sample management expertise including logistics and informed consent administration.
• Assay experience involving whole blood, cellular, tissue, ELISA, electrophysiology, HPLC and receptor binding.Recognized with multiple awards for scientific, technical, and administrative roles.
• Exceptional Science Award in 2006 for profiling the functional activity of muscarinic acetylcholine receptor (mAChR) antagonist compounds.
• Key member of R&D lead optimization team that discovered umeclidinium, the long-acting, once-daily, muscarinic antagonist (LAMA) component in GSK’s Incruse, Anoro and Trelegy Ellipta products. In addition, contributed.

Research in laboratory involved with physiological measurement of skeletal muscle fiber mechanics and energetics. Conducted contractile experiments with skinned rabbit and frog skeletal muscle fibers. Biochemical synthesis and purification of photo-labile (caged) nucleotides and phosphate derivatives; quantitative assay of nucleotides and phosphate.

B.S., Biology

Activities and Societies: Penn State Natatorium - lifeguard (1980-83)

Evening Coursework In Marketing, Economics

Education record

Activities and Societies: track, cross country, swim teams (9 varsity seasons)